All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
This product is the plasmid containing an encoded anti-MAP2K1 DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.
Sub CAT. | DMAb Clone | DMAb Host | Target Species | DMAb Isotype | DMAb Immunogen | |
DMAb-3723-FY | 25/MEK1 | Mouse | Human | IgG2a | Human MEK1 Recombinant Protein | |
DMAb-3724-FY | CBFYM-0006 | Human | Human | IgG1 | ||
DMAb-3725-FY | CBFYM-0053 | Mouse | Human | IgG1, k | Synthetic peptide corresponding to amino acid residues near the C-terminus conjugated to KLH | |
DMAb-3726-FY | CBFYM-0185 | Mouse | Human | IgG2a | ||
DMAb-3727-FY | CBFYM-0269 | Rabbit | Human | IgG | ||
DMAb-3728-FY | CBFYM-0333 | Mouse | Human | IgG1, k | Phosphorylated Human MEK1 Peptide | |
DMAb-3729-FY | CBFYM-0552 | Rabbit | Human | IgG | ||
DMAb-3730-FY | CBFYM-0553 | Mouse | Mouse | IgG1 | ||
DMAb-3731-FY | CBFYM-1414 | Mouse | Human | IgG2a | Synthetic peptide corresponding to a portion of MKK1/2 (MAP kinase kinase 1/2) | |
DMAb-3732-FY | CBFYM-1415 | Mouse | Human | IgG1, k | MEK1 antibody was raised in Mouse using a recombinant human protein purified from E.coli(His-MEK1) | |
DMAb-3733-FY | CBFYM-1416 | Mouse | Human | IgG2b | Protein expressed in 293T cell transfected with human MAP2K1 expression vector | |
DMAb-3734-FY | CBFYM-1417 | Mouse | Human | Mitogen Activated Protein Kinase Kinase 1 | ||
DMAb-3735-FY | CBFYM-1418 | Human | Human | Full length recombinant human MEK 1 expressed in Sf9 cells | ||
DMAb-3736-FY | CBFYM-1419 | Mouse | Human | IgG1 | Native MEK and recombinant MEK1 | |
DMAb-3737-FY | CBFYM-1420 | Mouse | Human | IgG1, k | Recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.Immunogen sequence: GRPLSSYGMD SRPPMAIFEL LDYIVNEPPP KLPSGVFSLE FQDFVNKCLI KNPAERADLK QLMVHAFIKR SDAEEVDFAG WLCSTIGLNQ PSTPTHAAGV | |
DMAb-3738-FY | CBFYM-1421 | Rabbit | Human | IgG | ||
DMAb-3739-FY | CBFYM-1422 | Mouse | Human | IgG1 | Full length human recombinant protein of human MAP2K1(NP_002746) produced in HEK293T cell | |
DMAb-3740-FY | CBFYM-1423 | Mouse | Human | IgG2a | Full length human recombinant protein of human MAP2K1(NP_002746) produced in HEK293T cell | |
DMAb-3741-FY | CBFYM-1424 | Rabbit | Human | IgG | Synthetic peptide (KLH coupled) corresponding to human MEK1 | |
DMAb-3742-FY | CBFYM-1425 | Mouse | Human | IgG | Protein expressed in 293T cell transfected with human MAP2K1 expression vector | |
DMAb-3743-FY | CBFYM-1426 | Mouse | Human | IgG2a | Full length MEK1 proteins | |
DMAb-3744-FY | CBFYM-1427 | Mouse | Human | IgG2a | E. coli-derived recombinant human MEK1, Lys2-Val393 (Ser218Asp, Ser222Asp) | |
DMAb-3745-FY | CBFYM-1428 | Mouse | Human | IgG1, k | Recombinant protein between 1-393 amino acids from human MP2K1 | |
DMAb-3746-FY | CBFYM-1429 | Rabbit | Human | IgG | Recognizes MEK1 | |
DMAb-3747-FY | CBFYM-1430 | Rabbit | Human | IgG | Recombinant peptide corresponding to amino acids surrounding the TEY motif in the activation loop of human phospho-MEK1 | |
DMAb-3748-FY | CBFYM-1431 | Mouse | Human | IgG1, k | A mouse immunized with a recombinant protein between 1-393 amino acids from human MP2K1 | |
DMAb-3749-FY | CBFYM-1432 | Mouse | Human | IgG2a | ||
DMAb-3750-FY | CBFYM-1433 | Mouse | Human | IgG1 | ||
DMAb-3751-FY | CBFYM-1434 | Rabbit | Human | |||
DMAb-3752-FY | CBFYM-1435 | Mouse | Human | IgG2a | Recombinant Xenopus MEK1 | |
DMAb-3753-FY | CBFYM-1436 | Mouse | Human | IgG1 | ||
DMAb-3754-FY | CBFYM-1437 | Mouse | Human |
There are currently no customer reviews or questions for Anti-MAP2K1 DNA-encoded mAb (DMAb), pVAX1 (DMAb-3723-FY). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION